View Older Stories View More Recent Stories
-
salesforce.com (CRM) PT Lowered to $365 at Baird
-
Wolfe Research Reiterates Outperform Rating on salesforce.com (CRM)
-
salesforce.com (CRM) PT Raised to $275 at Wells Fargo
-
salesforce.com (CRM) PT Raised to $225 at DA Davidson
-
Stifel Reiterates Buy Rating on salesforce.com (CRM)
-
salesforce.com (CRM) PT Raised to $404 at Morgan Stanley
-
JPMorgan Reiterates Overweight Rating on salesforce.com (CRM)
-
salesforce.com (CRM) PT Raised to $385 at Goldman Sachs
-
Citizens JMP Reiterates Market Outperform Rating on salesforce.com (CRM)
-
Wedbush Dan Ives' First Take on salesforce.com (CRM) Earnings, Stock Up 1.6pct After Hours
-
Evercore ISI First Look on salesforce.com (CRM) Earnings: 'Solid F1Q Results Help 'De-Risk' Updated FY26 Guide'
-
After-hours movers: NVIDIA, HP Inc., Salesforce, SentinelOne
-
Salesforce (CRM) Tops Q1 EPS by 4c, Beats on Revenue; Offers FY26 Guidance
-
Salesforce (CRM) call put ratio 1 call to 1 put into quarter results
-
Morgan Stanley Reiterates Overweight Rating on salesforce.com (CRM)
-
Loop Capital Reiterates Hold Rating on salesforce.com (CRM)
-
Salesforce (CRM) call put ratio 1 call to 1.1 puts into quarter results
-
Truist Securities Downgrades Informatica (INFA) to Hold
-
Salesforce Q1 preview: Checks remain mixed
-
TD Cowen Reiterates Buy Rating on salesforce.com (CRM)
-
William Blair Reiterates Outperform Rating on salesforce.com (CRM)
-
salesforce.com (CRM) PT Lowered to $350 at Canaccord Genuity
-
DA Davidson Adds Informatica (INFA) to STAMPEDE List of Special Situation Investment Ideas
-
DA Davidson on salesforce.com (CRM): 'we are hesitant to endorse the deal'
-
Salesforce (CRM) call put ratio 1.4 calls to 1 put into quarter results and outlook
-
Mizuho Reiterates Outperform Rating on salesforce.com (CRM)
-
salesforce.com (CRM) PT Lowered to $300 at UBS
-
Truist Securities Reiterates Buy Rating on salesforce.com (CRM), PT $400
-
Johnson Fistel Investigates Fairness of Proposed Sale of Informatica
-
Guggenheim on Informatica (INFA): 'We believe CRM faces material integration risks'
-
Evercore ISI Reiterates Outperform Rating on salesforce.com (CRM), PT $350, 'we continue to see the risk/reward skewing materially to the upside'
-
Raymond James Reiterates Strong Buy Rating on salesforce.com (CRM), PT $375, 'we see much more potential synergies outweighing the risks'
-
Wedbush Reiterates salesforce.com (CRM) at Outperform on "smart and strategic" Informatica (INFA) deal
-
Salesforce (CRM) to Acquire Informatica (INFA) for $25/sh Cash
-
Salesforce (CRM) Nears Deal to Buy Informatica (INFA) for $25/sh - WSJ
-
Salesforce (CRM) 30-day option implied volatility into expected release of quarter results
-
Salesforce (CRM) call put ratio 1 call to 1 put into quarter results and M&A headlines
-
salesforce.com (CRM) PT Lowered to $350 at BMO Capital, 'Expecting In-Line Quarter', 'We remain bullish on longer-term'
-
Salesforce (CRM) Trading 280 Handle in early session
-
Goldman Sachs Reiterates Buy Rating on salesforce.com (CRM)
-
Salesforce (CRM) Is Said In Talks To Acquire Informatica (INFA) - Bloomberg
-
salesforce.com (CRM) PT Raised to $340 at Wolfe Research, 'We see positive signal and momentum building'
-
RayJay on Veeva (VEEV): 'we haven’t heard any official designation on Bristol-Myers Squib’s plans for CRM going forward, our understanding is that CRM add-ons won’t be portable to Salesforce'
-
Stifel Reiterates Buy Rating on salesforce.com (CRM)
-
BMO Capital: ACN vs IBM Valuations
-
Citizens JMP Reiterates Market Outperform Rating on salesforce.com (CRM)
-
TD Cowen Reiterates Buy Rating on salesforce.com (CRM)
-
Salesforce (CRM) Introduces New Flexible Agentforce Pricing to Accelerate the Digital Labor Revolution
-
Salesforce (CRM) to Acquire Convergence.ai
-
Proof Mark Issues Fiduciary Letter to Salesforce (CRM) CEO Marc Benioff Over Governance Concerns and Board Silence on Red Flags

